Sun Pharma share price: Pharmaceutical company Sun Pharma shares were buzzing in trade on the last trading day of the week i.e. Friday, April 11, 2025. The rise in the Sun Pharma share price came ...

The results of exclusive research with people seeking health information online in the US, UK and Canada should be a wake-up call for pharma, says Richard Meyer. The results of a recent survey ...

India's pharmaceutical market experienced an 8.4% growth in FY25, driven by positive value growth in major therapies, according to market research firm Pharmarack. The cardiac segment led with a 10.8% ...

11/04/2025 – The Pharma Supply Chain & Logistics Innovation Programme 2025 is set to take place on May 27-28, 2025, at Mövenpick Hotel Basel, Switzerland. This high-impact conference will bring ...

Tomb Raider has a chartered history, with Lara Croft delving into ruins and tombs all over the world. Overcoming any and all obstacles set in her path, Lara has elevated herself into an exclusive ...

Mumbai-based Sun Pharma has received a favourable ruling from the US Court of Appeals for the Federal Circuit, paving way for the launch of Leqselvi in the USA, according to a company filing to ...

Pharma stocks such as Sun Pharma, Aurobindo Pharma, Dr Reddy's Lab, Cipla, Gland Pharma, Zydus Lifesciences and Lupin would be in action on Friday after the US President Donald Trump halted ...

The Trump administration's proposed tariffs on pharmaceuticals have caused significant market turmoil today, with major Pharma stocks plummeting globally. Despite pledges to increase U.S ...

In FY24, Indian pharmaceutical exports to the US were valued at approximately USD 8 billion. Riddhima Kanetkar Updated : Apr 09, 2025, 12:50 PM IST | Edited by : Riddhima Kanetkar US President Donald ...

On Tuesday night (local time), the US President announced that Tariffs on the Pharma sector were coming soon. The sector has so far been exempt from the Tariffs. To advertise here, Contact Us ...

Gifting allows recipients to access the article for free. The battle over the steep discounts pharmaceutical manufacturers give health care providers for drugs that go to uninsured and ...

Licensing agreements for Chinese drug candidates hit a record high in 2024, with large pharma in-licensing 28% of innovator drugs from Chinese biopharma companies. Total deal values of innovator drug ...